Pharma Consulting & Analytics Solutions Team

USA: Melody Marden

Melody Marden is a US-based pharma consulting & analytics Senior Director with over 30 years of life sciences and healthcare industry experience. Melody previously worked for a top 10 pharmaceutical company, driving strategic direction for all key brands, and for a leading PBM, developing the first national smoking-cessation disease management program (offered to 40 million). The protocols Melody developed became the basis for a national smoking cessation program available today, plus programs in diabetes, CHF, HTN, asthma, GERD, and others. Melody earned M.S., Evaluative Clinical Sciences at Geisel School of Medicine, Dartmouth College, where she studied epidemiology/biostatistics, clinical decision making, health policy and quality improvement, and survey design. She is certified in Managed Care through the American College of Managed Care Medicine. Melody was inducted into “International Who’s Who of Professional and Business Women”, recognizing contributions in fields of Informed Decision Making and Disease Management.

[email protected]

USA: Shahraz Niwaz

Shahraz Niwaz is a US-based pharma consulting & analytics Senior Director with over 10 years of medical, life sciences and healthcare industry experience, working for a global Life Sciences consulting firm, top global data company and global diagnostics company. Shahraz also conducted primary research as a British Heart Foundation fellow researching and coordinating a longitudinal dietary intervention trial. He holds a MSc in Toxicology from the University of Birmingham, UK, with his Masters Thesis results published in Atherosclerosis. Shahraz is fluent in English, Urdu, and Punjabi.

[email protected]

EMEA & India: Dr. Trajko Spasenovski

Dr. Trajko Spasenovski is a Europe-based pharma consulting & analytics Senior Director with over 20 years of medical, life sciences and healthcare industry experience. Trajko spent 10+ years in the molecular biology, microbiology, reagent space across both laboratory and diagnostic services, across 4 organizations, as well as over 6 years supporting top global life sciences companies in Europe as well as APAC and emerging markets. Trajko earned Doctor of Medicine from St Cyril and Methodius University, Macedonia, and a PhD in Molecular Microbiology from King’s College London with a thesis focused on “Modelling Bacterial Communities in Cystic Fibrosis Lung Infection”. Trajko has native Fluency in 5 languages - English, Macedonian, Croatian, Serbian, and Bulgarian.

[email protected]

Japan: Sonoko Sunaoshi

Sonoko Sunaoshi is a Japan-based pharma consulting & analytics Senior Director with over 15 years experience working in the life science and healthcare industries. Based in Tokyo, Japan, Sonoko has spent >12 years working in the pharma consulting & analytics space and over 5 years in preclinical and clinical laboratory services for the pharmaceutical, medical device and biotechnology industries. Sonoko is fluent in both English and Japanese.

[email protected]

Europe: Dr. Paul Verdin

Dr. Paul Verdin is the Head of Evaluate pharma consulting & analytics with over 15 years experience across academic research and consulting. Paul leads the development and management of Evaluate’s pharma consulting & analytics business incorporating all aspects of forecasting and valuation analysis, product strategy assessment, industry trend and outlook analysis, and data feed/API delivery. Paul has worked with a wide range of client organisations across the pharma ecosystem from startup biotechs seeking external perspectives into product strategy and positioning, to suppliers seeking insight into potential customer organisations, to large pharma Corporate Strategy groups providing insights directly to major pharma Executive teams. Paul has a PhD in Neuropharmacology (Lawes Trust Award studentship at University of Nottingham / Rothamsted Research).

日本: 黒坂宗久（くろさか・むねひさ）Ph.D.

20年以上にわたってアカデミア（日本および米国）、製薬企業、データコンサルティング企業での経験があります。現職Evaluateでは、 Consulting & AnalyticsチームのAPACシニアマネージャーとして主に日本の顧客とプロジェクトを進めています。日米のアカデミア、製薬企業、データコンサルティング企業で20年以上の知識・経験を活かし、顧客との議論を通じて課題を発見し、適切なデータソリューションを提供しています。米国国立がん研究所（NCI）の客員研究員として、生体内の炎症状況における白血球遊走の研究後、産業技術総合研究所（AIST）に移り、乳がんのマウスモデルを用いた骨転移を研究。製薬企業においては、基礎研究、製品（細胞治療）導入チームの編成・運営、PMDA対応などを経験。

USA: Joshua Levy

Joshua Levy is a US Evaluate pharma consulting & analytics Manager with over 10 years of experience in healthcare consulting, data science, and research. His expertise lies in leveraging market access analytics to answer targeted client questions related to market landscape, payer restrictions, and patient behaviour. He is also trained in advanced analytics for statistical modelling and trending of multivariate data. Previous projects include: “Payer contracting and patient assistance strategy on a product and portfolio level”, “Strategy workshop for large pharma company advising on payer contracting in the context of an anticipated launch of a competitor product”, and “Sizing of addressable market and volume forecasting for pipeline products”. Joshua holds a Master of Science in Cognitive Psychology from University of Massachusetts Amherst and undergraduate degrees from McGill University in Montréal, Canada